Home > PJ (current issue) > News / News Centre | Search

PJ Online homeThe Pharmaceutical Journal
Vol 278 No 7451 p544
12 May 2007

This article
Reprint   Photocopy

  Acrobat Reader


News summary


Primary care trusts' performers lists up for review

Lists kept by primary care trusts of health professionals and organisations approved to work in the NHS in England are being reviewed by the Department of Health.

The DoH wants to hear about the benefits and disadvantages of the current system, which requires doctors, dentists and pharmacy contractors (but not individual pharmacists) to be listed by PCTs so that they can be stopped from working in the NHS in cases of serious transgression.

The review is considering: whether some or all of the system is needed; replacing individual PCT lists with a central list; the consequences of leaving NHS disciplinary action with PCTs or transferring responsibility to professional bodies; how to remove operational difficulties if the system stays with PCTs; and what guidance is needed to make sure any new system works.

The review is intended to lead to a system that meets the Government’s aim following the reviews of medical and non-medical regulation. That aim is, the Government has said, that “professional regulation must create a framework that maintains the justified confidence of patients in those who care for them as the bedrock of safe and effective clinical practice and the foundation for effective relationships between patients and health professionals.”

So far as pharmacists are concerned, the review document says: “Plans to introduce supplementary list provisions for individual employee pharmacists were deferred in 2006. We were awaiting the outcome of the consultation on the regulation of pharmacists and the Royal Pharmaceutical Society’s duties and powers. That process is now complete and we are considering [the] next steps.”

Joy Wingfield, professor of pharmacy law and ethics at the University of Nottingham, said of the performers list system: “It’s a jeopardy too far. I’m glad to see that the review questions the need for the NHS list at all.” She added that PCTs need to apply consistent criteria for investigation and referral and expressed concern about the investigatory skills and competence of PCT staff.

Anyone wishing to contribute to the review can e-mail rab.harkins@dh.gsi.gov.uk before 15 June.

Back to Top


©The Pharmaceutical Journal